Myriad Genetics Expands Board of Directors with Two Additional Members
SALT LAKE CITY, Sept. 25, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN, “Myriad” or the “Company”), a global leader in molecular diagnostics and precision medicine, today announced the election of Colleen F. Reitan, age 60, and Lee N. …